Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 2581 AL 2595

The role of fatty acid amide hydrolase enzyme inhibitors in Alzheimer's disease

Jain S, Bisht A, Verma K, Negi S, Paliwal S, Sharma S.

Cell Biochem Funct. 2022 Mar;40(2):106-117. doi: 10.1002/cbf.3680. Epub 2021 Dec 21.

Tissue Plasminogen Activator in Central Nervous System Physiology and Pathology: From Synaptic Plasticity to Alzheimer's Disease

Stevenson TK, Moore SJ, Murphy GG, Lawrence DA.

Semin Thromb Hemost. 2022 Apr;48(3):288-300. doi: 10.1055/s-0041-1740265. Epub 2021 Dec 23.

Small Molecule Drugs Targeting Non-Coding RNAs as Treatments for Alzheimer's Disease and Related Dementias

Nguyen LD, Chau RK, Krichevsky AM.

Genes (Basel). 2021 Dec 17;12(12):2005. doi: 10.3390/genes12122005.

Computer-Based Drug Design of Positive Modulators of Store-Operated Calcium Channels to Prevent Synaptic Dysfunction in Alzheimer's Disease

Hunanyan L, Ghamaryan V, Makichyan A, Popugaeva E.

Int J Mol Sci. 2021 Dec 19;22(24):13618. doi: 10.3390/ijms222413618.

The molecular mechanism, targets, and novel molecules in the treatment of Alzheimer's disease

Verma A, Kumar Waiker D, Bhardwaj B, Saraf P, Shrivastava SK.

Bioorg Chem. 2022 Feb;119:105562. doi: 10.1016/j.bioorg.2021.105562. Epub 2021 Dec 16.

Impacts of oxidants and antioxidants on the emergence and progression of Alzheimer's disease

Goshtasbi H, Pakchin PS, Movafeghi A, Barar J, Castejon AM, Omidian H, Omidi Y.

Neurochem Int. 2022 Feb;153:105268. doi: 10.1016/j.neuint.2021.105268. Epub 2021 Dec 23.

Toward noninvasive brain stimulation 2.0 in Alzheimer's disease

Menardi A, Rossi S, Koch G, Hampel H, Vergallo A, Nitsche MA, Stern Y, Borroni B, Cappa SF, Cotelli M, Ruffini G, El-Fakhri G, Rossini PM, Dickerson B, Antal A, Babiloni C, Lefaucheur JP, Dubois B, Deco G, Ziemann U, Pascual-Leone A, Santarnecchi E.

Ageing Res Rev. 2022 Mar;75:101555. doi: 10.1016/j.arr.2021.101555. Epub 2021 Dec 30.

Probiotics for Alzheimer's Disease: A Systematic Review

Naomi R, Embong H, Othman F, Ghazi HF, Maruthey N, Bahari H.

Nutrients. 2021 Dec 22;14(1):20. doi: 10.3390/nu14010020.

Neurotrophic factors in Alzheimer's disease: pathogenesis and therapy

Lübke JH, Idoon F, Mohasel-Roodi M, Alipour F, Hami J, Ehteshampour A, Mostafaee H, Sadeghi A.

Acta Neurobiol Exp (Wars). 2021;81(4):314-327.

Basic Scientific Evidence Consistent with Etanercept Efficacy Against Alzheimer's Disease

Clark I.

Neuroscience. 2022 Feb 21;484:139. doi: 10.1016/j.neuroscience.2021.11.002. Epub 2021 Dec 22.

Could Mental and Physical Exercise Alleviate Alzheimer's Disease?

Radić B, Blažeković A, Duraković D, Jurišić-Kvesić A, Bilić E, Borovečki F.

Psychiatr Danub. 2021 Spring-Summer;33(Suppl 4):1267-1273.

Endophenotype-based in silico network medicine discovery combined with insurance record data mining identifies sildenafil as a candidate drug for Alzheimer's disease

Fang J, Zhang P, Zhou Y, Chiang CW, Tan J, Hou Y, Stauffer S, Li L, Pieper AA, Cummings J, Cheng F.

Nat Aging. 2021 Dec;1(12):1175-1188. doi: 10.1038/s43587-021-00138-z. Epub 2021 Dec 6.

Aducanumab and the FDA - where are we now?

Fillit H, Green A.

Nat Rev Neurol. 2021 Mar;17(3):129-130. doi: 10.1038/s41582-020-00454-9.

Aspirin in people with dementia, long-term benefits, and harms: a systematic review

Davis KAS, Bishara D, Molokhia M, Mueller C, Perera G, Stewart RJ.

Eur J Clin Pharmacol. 2021 Jul;77(7):943-954. doi: 10.1007/s00228-021-03089-x. Epub 2021 Jan 22.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias